The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the α2-adrenergic receptors in beta cells
Authors:
- J.E. de Leeuw van WeenenJWJ.E. de Leeuw van Weenen
- E.T. ParlevlietEPE.T. Parlevliet
- P. MaechlerPMP. Maechler
- L.M. HavekesLHL.M. Havekes
- J.A. RomijnJRJ.A. Romijn
- D.M. OuwensDOD.M. Ouwens
- H. PijlHPH. Pijl
- B. GuigasB. Guigas
- 1 June 2010
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 79 (12) , 1827-1836
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetesNutrition, 2009
- The Role of Incretins in Glucose Homeostasis and Diabetes TreatmentPharmacological Reviews, 2008
- Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical dataPediatric Diabetes, 2008
- AMP-activated/SNF1 protein kinases: conserved guardians of cellular energyNature Reviews Molecular Cell Biology, 2007
- Altered basal and stimulated accumbens dopamine release in obese OLETF rats as a function of age and diabetic statusAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Bromocriptine-Induced Hyperglycemia in Nonobese Diabetic Mice: Kinetics and Mechanisms of ActionThe Review of Diabetic Studies, 2007
- Islet cell failure in type 2 diabetesJournal of Clinical Investigation, 2006
- Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) miceLife Sciences, 1997
- Mechanism of bromocriptine-induced hyperglycaemiaLife Sciences, 1985
- Dopamine agonist-induced hyperglycemia in rats: Structure-activity relationships and mechanisms of actionEuropean Journal of Pharmacology, 1983